Please login to the form below

Not currently logged in
Email:
Password:

Chiesi extends research deal with NiKem

Chiesi Farmaceutici is to extend its research collaboration with NiKem Research, focused on developing treatments within the respiratory therapeutic area

Chiesi Farmaceutici is to extend its research collaboration with NiKem Research, focused on developing treatments within the respiratory therapeutic area.

The two companies have been working together since 2001, with the new deal extending their efforts until 2014.

The collaboration will see NiKem continue its work providing services such as design, lead optimisation and biochemical pharmacology within different therapeutic areas on a fee-for-service basis.

Italy-based Chiesi specialises in products for respiratory pathologies, special care medicine and cardiovascular diseases, with the extended NiKem agreement focused on respiratory illnesses such as asthma and COPD.

Giuseppe Giardina, CEO of NiKem, said: "The scientific and business relationship with Chiesi is rock solid and the current extension follows 10 years of continuous success for both parties in collaborating to identify novel compounds eligible to candidate status for clinical development."

6th September 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics